Ken Takashima

4PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMolecular targetsMicrofluidics and nanofluidicsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 23, 2025
A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model.

Runa Takahashi, Kazuki Yamamoto, Hikaru Toya

|Mar 12, 2025
Regulation of IL-17A-mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a.

Takanobu Yoshida, Ken Takashima, Yohana S Mtali

|Dec 12, 2024
Cholesterol restriction primes antiviral innate immunity via SREBP1-driven noncanonical type I IFNs.

Tasuku Nishimura, Takahisa Kouwaki, Ken Takashima

Pageof 1